Carlos Fonck
Senior Director, Head of Pharmacology & Toxicology at Audentes Therapeutics - San Francisco, California, US
Carlos Fonck's Colleagues at Audentes Therapeutics
Megan Sullivan
Vice President, Global Customer Experience & Commercial Innovation
Stephany Turano
Senior Manager, Clinical Operations – TMF Oversight & Management
Carlos Fonck's Contact Details
(415) 818-1005
San Francisco Bay Area
Audentes Therapeutics
Carlos Fonck's Company Details
Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients. If you are interested in learning more about our company, please do not hesitate to contact us.